Bedrijfstakpensioenfonds Voor DE Media PNO Raises Holdings in Danaher Co. (NYSE:DHR)

Bedrijfstakpensioenfonds Voor DE Media PNO grew its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 21.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 67,000 shares of the conglomerate's stock after buying an additional 12,000 shares during the period. Danaher accounts for 2.0% of Bedrijfstakpensioenfonds Voor DE Media PNO's investment portfolio, making the stock its 21st largest position. Bedrijfstakpensioenfonds Voor DE Media PNO's holdings in Danaher were worth $15,492,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. GHP Investment Advisors Inc. increased its stake in Danaher by 540.0% in the 3rd quarter. GHP Investment Advisors Inc. now owns 160 shares of the conglomerate's stock worth $40,000 after acquiring an additional 135 shares during the last quarter. Koshinski Asset Management Inc. increased its stake in Danaher by 16.2% in the 3rd quarter. Koshinski Asset Management Inc. now owns 1,118 shares of the conglomerate's stock worth $277,000 after acquiring an additional 156 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO increased its stake in Danaher by 0.4% in the 3rd quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 12,904 shares of the conglomerate's stock worth $3,201,000 after acquiring an additional 54 shares during the last quarter. Walkner Condon Financial Advisors LLC increased its stake in Danaher by 6.6% in the 3rd quarter. Walkner Condon Financial Advisors LLC now owns 906 shares of the conglomerate's stock worth $225,000 after acquiring an additional 56 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its stake in Danaher by 20.1% in the 3rd quarter. Valeo Financial Advisors LLC now owns 12,396 shares of the conglomerate's stock worth $3,075,000 after acquiring an additional 2,076 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance


Shares of DHR traded up $0.78 during trading hours on Friday, hitting $246.58. The stock had a trading volume of 2,710,446 shares, compared to its average volume of 2,710,897. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.37. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $259.00. The firm has a market capitalization of $182.64 billion, a PE ratio of 41.79, a PEG ratio of 3.78 and a beta of 0.83. The stock has a fifty day moving average price of $248.87 and a 200 day moving average price of $231.16.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. Danaher's quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.36 earnings per share. Analysts anticipate that Danaher Co. will post 7.65 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. This is an increase from Danaher's previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher's payout ratio is presently 18.31%.

Insider Activity

In other news, CEO Rainer Blair sold 47,175 shares of the business's stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the transaction, the chief executive officer now directly owns 115,995 shares in the company, valued at $28,908,273.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Danaher news, Director Teri List sold 3,289 shares of the business's stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the sale, the director now directly owns 19,726 shares of the company's stock, valued at $4,898,360.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Rainer Blair sold 47,175 shares of the business's stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the sale, the chief executive officer now directly owns 115,995 shares in the company, valued at $28,908,273.90. The disclosure for this sale can be found here. Insiders have sold 106,565 shares of company stock worth $26,641,364 over the last ninety days. Corporate insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on DHR shares. KeyCorp increased their price objective on Danaher from $260.00 to $290.00 and gave the company an "overweight" rating in a research report on Thursday, February 1st. Citigroup increased their target price on Danaher from $280.00 to $290.00 and gave the company a "buy" rating in a report on Wednesday. HSBC upgraded Danaher from a "hold" rating to a "buy" rating and increased their target price for the company from $250.00 to $280.00 in a report on Wednesday, April 17th. TD Cowen increased their target price on Danaher from $280.00 to $290.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Royal Bank of Canada increased their price objective on Danaher from $254.00 to $282.00 and gave the stock an "outperform" rating in a report on Wednesday, January 31st. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $270.00.

Read Our Latest Analysis on DHR

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Danaher right now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: